Lung Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Diagnosed clinically or pathologically as stage IIa-IIIB lung cancer; (2) 18 <= Age <= 80 years old; (3) Patients scheduled for surgical treatment at West China Hospital of Sichuan University; (4) Patients who plan to undergo 2-3 cycles of neoadjuvant chemotherapy combined with immunotherapy before surgery; (5) There are no potential contraindications related to pulmonary rehabilitation, including those who have experienced myocardial infarction or cerebrovascular accidents within six months; Chronic heart failure, unstable angina, severe arrhythmia, severe left heart dysfunction, acute pulmonary embolism or pulmonary embolism, severe lower limb vasculitis or limb dysfunction, etc; (6) Those who agree to be included in the study and sign the informed consent form after being informed of their condition.
Exclusion criteria
Exclusion criteria: (1) Incompatible collaborators (mental disorders, consciousness disorders, intellectual disabilities, etc.); (2) Individuals who cannot tolerate pulmonary rehabilitation training; (3) Patients with contraindications for pulmonary rehabilitation (as above); (4) Other exercise related taboos, such as active hemoptysis, untreated pneumothorax, etc; (5) Pregnant or lactating subjects; (6) Those who are unwilling or unable to cooperate with research requirements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pulmonary complication rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Static lung function ;Assessment of cardiorespiratory related functions;Quality of life Assessment; | — |
Countries
China
Contacts
West China Hospital of Sichuan University